EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 3.0

Is Rituximab Suitable for Patients with Idiopathic Membranous Nephropathy Who are Seronegative for Anti-PLA2R Antibody?

Yang Yang, Xiaojie Xie, Fan Yuan, Fang Zeng, Yu Wang, Ran Zhang, Wenjun Yan, Kaiping Luo, Daijin Ren, Gaosi Xu

Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-10

DOI: 10.2147/dddt.s601777 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Yang Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China. Hauptthemen laut MEDLINE: Glomerulonephritis, Membranous, Receptors, Phospholipase A2, Rituximab, Autoantibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, MembranousReceptors, Phospholipase A2RituximabAutoantibodiesHumansFemaleMaleMiddle AgedRetrospective StudiesAdultRemission InductionAgedImmunosuppressive Agents

Stichwörter der Autor:innen

anti-PLA2R antibodyidiopathic membranous nephropathyproteinuriaremission

Substanzen

Receptors, Phospholipase A2RituximabPLA2R1 protein, humanAutoantibodiesImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Nephrology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.
  • Department of Nephrology, Yingtan 184 Hospital, Yingtan, People's Republic of China.
  • Department of Nephrology, the Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University, Ganzhou, People's Republic of China.
  • Department of Nephrology, the First Affiliated Hospital of Gannan Medical University, Ganzhou, People's Republic of China.
  • Department of Health Management Center, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, People's Republic of China.

Zitieren

APA

Yang, Y., Xie, X., Yuan, F., Zeng, F., Wang, Y., Zhang, R., Yan, W., Luo, K., Ren, D., & Xu, G. (2026). Is Rituximab Suitable for Patients with Idiopathic Membranous Nephropathy Who are Seronegative for Anti-PLA2R Antibody?. Drug Design, Development and Therapy, Volume 20, 1-10. https://doi.org/10.2147/dddt.s601777

Vancouver

Yang Y, Xie X, Yuan F, Zeng F, Wang Y, Zhang R, et al. Is Rituximab Suitable for Patients with Idiopathic Membranous Nephropathy Who are Seronegative for Anti-PLA2R Antibody?. Drug Design, Development and Therapy. 2026;Volume 20:1-10. doi:10.2147/dddt.s601777

BibTeX
@article{Yang2026,
  author = {Yang, Yang and Xie, Xiaojie and Yuan, Fan and Zeng, Fang and Wang, Yu and Zhang, Ran and Yan, Wenjun and Luo, Kaiping and Ren, Daijin and Xu, Gaosi},
  title = {Is Rituximab Suitable for Patients with Idiopathic Membranous Nephropathy Who are Seronegative for Anti-PLA2R Antibody?},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--10},
  doi = {10.2147/dddt.s601777}
}
Kostenlos starten →